PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $319,000 | +9.6% | 381,955 | +78.2% | 0.02% | +30.8% |
| Q1 2017 | $291,000 | +1516.7% | 214,400 | +865.4% | 0.01% | +1200.0% |
| Q1 2016 | $18,000 | -77.8% | 22,208 | -72.3% | 0.00% | -75.0% |
| Q4 2015 | $81,000 | +161.3% | 80,108 | +197.3% | 0.00% | +300.0% |
| Q3 2015 | $31,000 | -40.4% | 26,944 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $52,000 | 0.0% | 26,944 | -8.2% | 0.00% | 0.0% |
| Q1 2015 | $52,000 | -3.7% | 29,344 | -0.3% | 0.00% | 0.0% |
| Q4 2014 | $54,000 | +80.0% | 29,444 | +135.1% | 0.00% | +100.0% |
| Q3 2014 | $30,000 | -61.0% | 12,526 | -26.3% | 0.00% | -75.0% |
| Q1 2014 | $77,000 | -6.1% | 17,000 | -20.3% | 0.00% | 0.0% |
| Q4 2013 | $82,000 | -27.4% | 21,318 | -15.3% | 0.00% | -33.3% |
| Q3 2013 | $113,000 | -37.6% | 25,163 | -32.1% | 0.01% | 0.0% |
| Q2 2013 | $181,000 | – | 37,063 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|